Active principles | Rating | Bibliogr. | Expand | |
---|---|---|---|---|
1 | Norpregnadienes | 100 | + | |
2 | Botulinum Toxins, Type A | 48 | + | |
3 | Nystatin | 16 | + | |
4 | Ebola Vaccines | 15 | + | |
5 | Viral Envelope Proteins | 10 | + | |
6 | Viral Matrix Proteins | 9 | + | |
7 | DNA, Recombinant | 8 | + | |
8 | 2,4-Dinitrophenol | 7 | + | |
9 | Gene Products, gag | 7 | + | |
10 | Gene Products, env | 7 | + | |
11 | Viral Vaccines | 7 | + | |
12 | Aminopterin | 7 | + | |
13 | p-Azobenzenearsonate | 6 | + | |
14 | Miconazole | 6 | + | |
15 | Membrane Glycoproteins | 6 | + | |
16 | Connexins | 6 | + | |
17 | Colchicine | 6 | + | |
18 | Vaccines, Synthetic | 6 | + | |
19 | Luminescent Proteins | 5 | + | |
20 | Viral Structural Proteins | 5 | + | |
21 | Levamisole | 5 | + | |
22 | Fluorouracil | 5 | + | |
23 | Antibodies, Viral | 5 | + | |
24 | Interferon Type I | 5 | + | |
25 | Green Fluorescent Proteins | 5 | + | |
26 | Leucovorin | 5 | + | |
27 | Chlorhexidine | 4 | + | |
28 | Viral Proteins | 4 | + | |
29 | Antibodies, Neutralizing | 4 | + | |
30 | SAIDS Vaccines | 3 | + | |
31 | Gels | 3 | + | |
32 | AIDS Vaccines | 3 | + | |
33 | Interferons | 3 | + | |
34 | Thalidomide | 3 | + | |
35 | Taxoids | 3 | + | |
36 | Triazines | 3 | + | |
37 | Doxorubicin | 3 | + | |
38 | Vaccines, Attenuated | 3 | + | |
39 | Deoxycytidine | 2 | + | |
40 | Plant Extracts | 2 | + | |
41 | Interferon-gamma | 2 | + | |
42 | Paclitaxel | 2 | + | |
43 | Recombinant Proteins | 2 | + | |
44 | Sirolimus | 2 | + | |
45 | Cisplatin | 1 | + |